These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21791642)

  • 1. MicroRNA expression and outcome in resected NSCLC--letter.
    Kageyama S; Takagi Y; Sawada T; Kageyama-Yahara N; Shibuya M
    Cancer Res; 2011 Aug; 71(15):5357; author reply 5358-9. PubMed ID: 21791642
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
    Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer.
    Navarro A; Diaz T; Gallardo E; Viñolas N; Marrades RM; Gel B; Campayo M; Quera A; Bandres E; Garcia-Foncillas J; Ramirez J; Monzo M
    J Surg Oncol; 2011 Apr; 103(5):411-5. PubMed ID: 21400525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
    Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
    Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.
    Takamizawa J; Konishi H; Yanagisawa K; Tomida S; Osada H; Endoh H; Harano T; Yatabe Y; Nagino M; Nimura Y; Mitsudomi T; Takahashi T
    Cancer Res; 2004 Jun; 64(11):3753-6. PubMed ID: 15172979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting.
    Wu DW; Cheng YW; Wang J; Chen CY; Lee H
    Cancer Res; 2010 Dec; 70(24):10392-401. PubMed ID: 21159652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non small-cell lung cancer.
    Leo F; De Pas T; Catalano G; Piperno G; Curigliano G; Solli P; Veronesi G; Petrella F; Spaggiari L
    J Natl Cancer Inst; 2007 Aug; 99(15):1210; author reply 1210-1. PubMed ID: 17652281
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
    Rusch V; Baselga J; Cordon-Cardo C; Orazem J; Zaman M; Hoda S; McIntosh J; Kurie J; Dmitrovsky E
    Cancer Res; 1993 May; 53(10 Suppl):2379-85. PubMed ID: 7683573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T; Osaki T; Nose N; Ichiki Y; Inoue M; Imoto H; Yoshimatsu T; Kodate M; Uramoto H; Mizoue T; Yano K; Yasumoto K
    Anticancer Res; 2000; 20(1B):505-10. PubMed ID: 10769714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA signature predicts survival and relapse in lung cancer.
    Yu SL; Chen HY; Chang GC; Chen CY; Chen HW; Singh S; Cheng CL; Yu CJ; Lee YC; Chen HS; Su TJ; Chiang CC; Li HN; Hong QS; Su HY; Chen CC; Chen WJ; Liu CC; Chan WK; Chen WJ; Li KC; Chen JJ; Yang PC
    Cancer Cell; 2008 Jan; 13(1):48-57. PubMed ID: 18167339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with resectable stage IIIA (N2) NSCLC.
    Azzoli CG
    J Surg Oncol; 2006 Dec; 94(7):551-2. PubMed ID: 17111389
    [No Abstract]   [Full Text] [Related]  

  • 13. [Expression of major histocompatibility complex of advanced non-small cell lung cancer (NSCLC)].
    Hirata S; Kubo Y; Kokubo T; Kitada M; Nosaka T
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):138-43. PubMed ID: 8717260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic role of Bcl-2 mRNA expression in curatively resected non-small cell lung cancer (NSCLC).
    Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
    Lung Cancer; 2010 Oct; 70(1):82-7. PubMed ID: 20064672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer.
    Jeremic B
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):444-5. PubMed ID: 12579133
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less is more… (more or less…).
    Murthy SC
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):670-2. PubMed ID: 21335124
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of postoperative adjuvant therapy for resected non-small cell lung cancer--an evidence-based review].
    Tanaka F; Wada H
    Gan To Kagaku Ryoho; 2006 Mar; 33(3):300-6. PubMed ID: 16531708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant treatment for early stages of non-small-cell lung carcinoma (NSCLC)].
    Papadakis E
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S25-8. PubMed ID: 11924238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Adjuvant chemotherapy in the early stages of non-small cell bronchial cancers].
    Le Chevalier T
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S31-2. PubMed ID: 12538932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.